This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Leading USA based genetic testing brand officially enters the Indian market
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Subscribe To Our Newsletter & Stay Updated
